Analysis of 'Revolving Door' Patients in Opioid Dependent Patients: the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

Value Health. 2014 Nov;17(7):A456. doi: 10.1016/j.jval.2014.08.1250. Epub 2014 Oct 26.

Authors

E Clay¹, V Zah², E Kharitonova¹, J Ruby³, S Aballéa¹, A Khemiri⁴

Affiliations

¹ Creativ-Ceutical, Paris, France.
² ZRx Outcomes Research Inc., Belgrade, Serbia and Montenegro.
³ Reckitt Benckiser Pharmaceuticals, Inc. /NA, Richmond, VA, USA.
⁴ Creativ-Ceutical, Tunis, Tunisia.

PMID: 27201267
DOI: 10.1016/j.jval.2014.08.1250

No abstract available